Trade FibroGen, Inc - FGEN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.23 |
| Open | 1.26 |
| 1-Year Change | -35.05% |
| Day's Range | 1.03 - 1.27 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 1.22 | -0.02 | -1.61% | 1.24 | 1.31 | 1.20 |
| Jul 24, 2024 | 1.24 | 0.02 | 1.64% | 1.22 | 1.34 | 1.18 |
| Jul 23, 2024 | 1.23 | 0.03 | 2.50% | 1.20 | 1.50 | 1.18 |
| Jul 22, 2024 | 1.23 | 0.19 | 18.27% | 1.04 | 1.25 | 1.04 |
| Jul 19, 2024 | 1.03 | 0.01 | 0.98% | 1.02 | 1.06 | 0.98 |
| Jul 18, 2024 | 1.02 | -0.05 | -4.67% | 1.07 | 1.07 | 1.01 |
| Jul 17, 2024 | 1.05 | -0.05 | -4.55% | 1.10 | 1.16 | 1.04 |
| Jul 16, 2024 | 1.12 | 0.07 | 6.67% | 1.05 | 1.14 | 1.00 |
| Jul 15, 2024 | 1.04 | 0.02 | 1.96% | 1.02 | 1.08 | 1.01 |
| Jul 12, 2024 | 1.03 | 0.02 | 1.98% | 1.01 | 1.11 | 0.99 |
| Jul 11, 2024 | 0.95 | 0.03 | 3.26% | 0.92 | 1.02 | 0.92 |
| Jul 10, 2024 | 0.88 | 0.06 | 7.32% | 0.82 | 0.93 | 0.82 |
| Jul 9, 2024 | 0.82 | 0.01 | 1.23% | 0.81 | 0.83 | 0.76 |
| Jul 8, 2024 | 0.79 | 0.09 | 12.86% | 0.70 | 0.82 | 0.69 |
| Jul 5, 2024 | 0.69 | -0.01 | -1.43% | 0.70 | 0.71 | 0.66 |
| Jul 3, 2024 | 0.67 | -0.05 | -6.94% | 0.72 | 0.72 | 0.66 |
| Jul 2, 2024 | 0.72 | -0.03 | -4.00% | 0.75 | 0.77 | 0.71 |
| Jul 1, 2024 | 0.74 | -0.14 | -15.91% | 0.88 | 0.89 | 0.74 |
| Jun 28, 2024 | 0.88 | -0.11 | -11.11% | 0.99 | 1.03 | 0.87 |
| Jun 27, 2024 | 1.00 | -0.04 | -3.85% | 1.04 | 1.04 | 0.99 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
FibroGen, Inc Company profile
About FibroGen Inc
FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) biology, 2-oxoglutarate enzymology, and connective tissue growth factor (CTGF) biology to advance medicines for the treatment of anemia, fibrotic disease, and cancer. The Company’s product Roxadustat is an oral small molecule inhibitor of HIF-prolyl hydroxylase (HIF-PH) activity for the treatment of anemia caused by chronic kidney disease (CKD). It is also developing Roxadustat for anemia associated with myelodysplastic syndromes (MDS). The Company is also developing Roxadustat for the treatment of chemotherapy-induced anemia (CIA). Pamrevlumab, an anti-CTGF human monoclonal antibody for the treatment of idiopathic pulmonary fibrosis (IPF), locally advanced unresectable pancreatic cancer (LAPC), and Duchenne muscular dystrophy (DMD).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, FibroGen Inc revenues increased 33% to $235.3M. Net loss increased 53% to $290M. Revenues reflect Europe segment increase of 95% to $131.2M. Higher net loss reflects Research and Development -Balancing increase of 68% to $346.5M (expense), General and Administrative -Balancing increase of 27% to $89.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$2.11 to -$3.14.
| Industry: | Biotechnology & Medical Research (NEC) |
409 Illinois Street
SAN FRANCISCO
CALIFORNIA 94158
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com